technology
kē jì
科技
Novo Nordisk (pharmaceutical company)
Nuòhé Nuòdé
诺和诺德
with
yǔ
与
OpenAI (AI company)
OpenAI
OpenAI
to cooperate / partnership
hézuò
合作
will (future marker)
jiāng
将
artificial intelligence / AI
réngōng zhìnéng
人工智能
to integrate into / to embed in
róngrù
融入
drugs / medicine
yàowù
药物
research and development / R&D
yánfā
研发
entire process / end-to-end workflow
quán liúchéng
全流程
Denmark
Dānmài
丹麦
pharmaceutical / drug manufacturing
zhìyào
制药
company
gōngsī
公司
Novo Nordisk
Nuòhé Nuòdé
诺和诺德
with
yǔ
与
OpenAI (AI company)
OpenAI
OpenAI
to reach / to achieve
dáchéng
达成
strategic / strategy
zhànlüè
战略
cooperation / partnership
hézuò
合作
will (future marker)
jiāng
将
artificial intelligence / AI
réngōng zhìnéng
人工智能
to integrate into / to embed in
róngrù
融入
drug research and development
yàowù yánfā
药物研发
production / manufacturing
shēngchǎn
生产
and
hé
和
supply chain
gōngyìng liàn
供应链
entire process / end-to-end workflow
quán liúchéng
全流程
cooperation / partnership
hézuò
合作
key focus / priority
zhòngdiǎn
重点
is / to be
shì
是
to accelerate / to speed up
jiāsù
加速
to discover / discovery
fāxiàn
发现
obesity
féipàngzhèng
肥胖症
and
hé
和
diabetes
tángniàobìng
糖尿病
new treatments / new therapies
xīn liáofǎ
新疗法
full / comprehensive
quánmiàn
全面
deployment / to deploy
bùshǔ
部署
plan / planned
jìhuà
计划
by (formal time marker)
yú
于
end of 2026
2026 nián dǐ
2026年底
to complete / to finish
wánchéng
完成
May 4, 2026 at 10:50 AM
Denmark
Dānmài
丹麦
pharmaceutical / drug manufacturing
zhìyào
制药
giant / major player
jùtóu
巨头
Novo Nordisk (pharmaceutical company)
Nuòhé Nuòdé
诺和诺德
to announce / to declare
xuānbù
宣布
with
yǔ
与
OpenAI (AI company)
OpenAI
OpenAI
to establish / to form
jiànlì
建立
strategic / strategy
zhànlüè
战略
cooperation / partnership
hézuò
合作
partnership / partner relationship
huǒbàn guānxi
伙伴关系
both parties / the two sides
shuāngfāng
双方
to plan / plan
jìhuà
计划
will (future marker)
jiāng
将
artificial intelligence / AI
réngōng zhìnéng
人工智能
technology / techniques
jìshù
技术
to integrate into / to embed in
róngrù
融入
company
gōngsī
公司
from
cóng
从
drug research and development
yàowù yánfā
药物研发
to / through
dào
到
production / manufacturing
shēngchǎn
生产
and
hé
和
supply chain
gōngyìng liàn
供应链
management
guǎnlǐ
管理
(attributive particle)
de
的
entire process / end-to-end workflow
quán liúchéng
全流程
cooperation
hézuò
合作
key focus / priority
zhòngdiǎn
重点
one of (the)
zhī yī
之一
is / to be
shì
是
to accelerate / to speed up
jiāsù
加速
to discover / discovery
fāxiàn
发现
new type / novel
xīnxíng
新型
obesity
féipàngzhèng
肥胖症
and
hé
和
diabetes
tángniàobìng
糖尿病
treatment / to treat
zhìliáo
治疗
program / solution
fāng an
方案
Novo Nordisk
Nuòhé Nuòdé
诺和诺德
to state / to indicate
biǎoshì
表示
this time / this
cǐ cì
此次
cooperation / partnership
hézuò
合作
to aim at / with the goal of
zhǐzài
旨在
to enhance / to strengthen
zēngqiáng
增强
scientists
kēxuéjiā
科学家
(possessive particle)
de
的
research
yánjiū
研究
capabilities / ability
nénglì
能力
rather than / not
ér fēi
而非
to replace / to substitute
qǔdài
取代
them / they
tāmen
他们
according to / in accordance with
ànzhào
按照
plan / the plan
jìhuà
计划
full / comprehensive
quánmiàn
全面
deployment / to deploy
bùshǔ
部署
will
jiāng
将
by (formal time marker)
yú
于
end of 2026
2026 nián dǐ
2026年底
to complete / to finish
wánchéng
完成
artificial intelligence / AI
réngōng zhìnéng
人工智能
currently (progressive marker)
zhèng
正
increasingly more / more and more
yuè lái yuè duō
越来越多
(adverbial particle)
de
地
(passive marker)
bèi
被
pharmaceutical / drug manufacturing
zhìyào
制药
companies
gōngsī
公司
to be used for
yòngyú
用于
to improve / to raise
tígāo
提高
new drugs
xīn yào
新药
research and development / R&D
yánfā
研发
efficiency
xiàolǜ
效率